Christina A Hewes1, Kenneth E Sullins. 1. Marion DuPont Scott Equine Medical Center, Virginia-Maryland Regional College of Veterinary Medicine, Leesburg, VA 20177, USA.
Abstract
OBJECTIVE: To determine outcome for equids with cutaneous neoplasms treated with cisplatin-containing biodegradable beads, alone or in conjunction with debulking. DESIGN: Retrospective case series. ANIMALS: 56 horses, 1 zebra, 1 donkey, and 1 mule. PROCEDURES: Medical records were reviewed. Follow-up information was obtained through telephone conversations with owners and trainers of the animals. RESULTS: 22 tumors were sarcoids, 6 were fibrosarcomas, 1 was a fibroma, 2 were peripheral nerve sheath tumors, 11 were squamous cell carcinomas, 14 were melanomas (13 gray horses and 1 bay horse), 1 was a lymphosarcoma, 1 was an adenocarcinoma, and 1 was a basal cell tumor. Forty-five (76%) animals underwent conventional or laser debulking of the tumor prior to bead implantation. Forty of 48 (83%) animals for which long-term follow-up information was available were relapse free 2 years after treatment. This included 20 of 22 animals with spindle cell tumors (including 11/13 horses with sarcoids), 6 of 10 animals with squamous cell carcinomas, 13 of 14 animals with melanomas, and 2 of 3 animals with other tumor types. Adverse effects were minimal. CONCLUSIONS AND CLINICAL RELEVANCE: Results suggest that implantation of cisplatin-containing biodegradable beads, with or without tumor debulking, may be an effective treatment for equidae with various cutaneous neoplasms.
OBJECTIVE: To determine outcome for equids with cutaneous neoplasms treated with cisplatin-containing biodegradable beads, alone or in conjunction with debulking. DESIGN: Retrospective case series. ANIMALS: 56 horses, 1 zebra, 1 donkey, and 1 mule. PROCEDURES: Medical records were reviewed. Follow-up information was obtained through telephone conversations with owners and trainers of the animals. RESULTS: 22 tumors were sarcoids, 6 were fibrosarcomas, 1 was a fibroma, 2 were peripheral nerve sheath tumors, 11 were squamous cell carcinomas, 14 were melanomas (13 gray horses and 1 bay horse), 1 was a lymphosarcoma, 1 was an adenocarcinoma, and 1 was a basal cell tumor. Forty-five (76%) animals underwent conventional or laser debulking of the tumor prior to bead implantation. Forty of 48 (83%) animals for which long-term follow-up information was available were relapse free 2 years after treatment. This included 20 of 22 animals with spindle cell tumors (including 11/13 horses with sarcoids), 6 of 10 animals with squamous cell carcinomas, 13 of 14 animals with melanomas, and 2 of 3 animals with other tumor types. Adverse effects were minimal. CONCLUSIONS AND CLINICAL RELEVANCE: Results suggest that implantation of cisplatin-containing biodegradable beads, with or without tumor debulking, may be an effective treatment for equidae with various cutaneous neoplasms.
Authors: Jacqueline V J Cavalcanti; Kimberly A Selting; Mai T Ngo; Christine K Tran Hoang; David J Schaeffer; Timothy M Fan; Brendan A C Harley; Heidi Phillips Journal: Am J Vet Res Date: 2022-05-14 Impact factor: 1.055
Authors: Emily Wenande; Uffe H Olesen; Malene R Boesen; Daniel P Persson; Catharina M Lerche; Stefan Stürup; Bente Gammelgaard; Søren Husted; R Rox Anderson; Merete Haedersdal Journal: Drug Deliv Date: 2018-11 Impact factor: 6.419
Authors: Lisa A Weber; Jessica Meißner; Julien Delarocque; Jutta Kalbitz; Karsten Feige; Manfred Kietzmann; Anne Michaelis; Reinhard Paschke; Julia Michael; Barbara Pratscher; Jessika-M V Cavalleri Journal: BMC Vet Res Date: 2020-02-05 Impact factor: 2.741
Authors: Lucy Va Metcalfe; Peter J O'Brien; Stratos Papakonstantinou; Stephen D Cahalan; Hester McAllister; Vivienne E Duggan Journal: Ir Vet J Date: 2013-11-06 Impact factor: 2.146